Some of our cancer centers are experiencing issues.  View More Important Notifications x
texas oncology more breakthroughs. more victories



Estil Vance, M.D.

General Summary


Dr. Vance received his M.D. from Johns Hopkins University School of Medicine in Baltimore, Maryland, where he completed his internship and residency. He completed fellowships at Harvard Medical School, Dana-Farber Cancer Institute in Boston, Massachusetts, Brigham and Women’s Hospital, and Harvard-MIT Health Sciences and Technology.

Medical Practice

Research Interest

In addition to his interest and experience in blood and marrow transplantation, Estil A. Vance III, M.D., is an expert in the field of oncology-related infections.

Surgery Locations

Other Information

Accolades & Memberships

Dr. Vance was formerly a medicine instructor at Harvard School of Medicine and Dana-Farber Cancer Institute and an associate physician at Brigham & Women’s Hospital.

Community Service


  • Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem-cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.

    Blood, 2007